Patents Assigned to NIR Diagnostics, Inc.
  • Patent number: 7933005
    Abstract: A device for measuring a compound with in a sample both non-invasively and invasively is provided. The devise comprised a source of electromagnetic radiation (EMR) operatively coupled to a power source, one or more receptors and a detector. The one or more receptors shaped to receive a body part and a sample holder and optically coupled to the source of EMR by one or more radiation guiding elements. The radiation guiding element comprising an input in operable association with the source of EMR, and an output in operable association with a detector and coupled to a processing system.
    Type: Grant
    Filed: November 21, 2006
    Date of Patent: April 26, 2011
    Assignee: NIR Diagnostics Inc.
    Inventors: Duncan MacIntyre, Ash Kaushal, Paul Endersby
  • Publication number: 20090168049
    Abstract: A method for measuring the concentration of a compound in the blood of a part of a subject is provided. An invasive or non-invasive sample of blood may be used for this determination. Also provided is a device for measuring the concentration of a compound in the blood of a subject. The device comprises a source of electromagnetic radiation, a holder, a detector and a processing system.
    Type: Application
    Filed: August 24, 2006
    Publication date: July 2, 2009
    Applicant: NIR Diagnostics, Inc
    Inventors: Ash Kaushal, Duncan Maclntyre
  • Patent number: 7449339
    Abstract: A method and apparatus for measuring Tot-Hb in a sample are provided. The method involves collecting absorbance measurements of a sample using a spectroscopic apparatus that includes a first primary calibration algorithm for one of Oxy-Hb, “Oxy-Hb plus Deoxy-Hb”, or “Total-Hb minus Met-Hb” and a second primary calibration algorithm for one or more than one of Met-Hb, Carboxy-Hb, or Sulf-Hb, or includes a third primary calibration algorithm obtained by adding terms of the first primary calibration algorithm and the second primary calibration algorithm together. Followed by predicting either a first value for one of Oxy-Hb, “Oxy-Hb plus Deoxy-Hb,” or “Total-Hb minus Met-Hb” and predicting second value for one or more than one of Met-Hb, Carboxy-Hb, or Sulf-Hb in the sample and adding the first and second value together, or predicting a value for Total-Hb.
    Type: Grant
    Filed: May 14, 2004
    Date of Patent: November 11, 2008
    Assignee: NIR Diagnostics Inc.
    Inventors: James Samsoondar, Duncan Maclntyre
  • Publication number: 20080198361
    Abstract: The present invention provides a method of measuring the concentration of a compound and a value of oxygen saturation in the blood of a part of a subject. Also provided is a device for carrying out the disclosed method. The method relates to measuring the concentration of a compound and a value of oxygen saturation in the blood part of a subject, and correlating the measured concentration of the compound and/or the value of oxygen saturation in the blood to a specific clinical condition. The device comprises a polychromatic light source, a receptor, a detector, and a processing system comprising a calibration algorithm.
    Type: Application
    Filed: March 3, 2006
    Publication date: August 21, 2008
    Applicant: NIR DIAGNOSTICS INC.
    Inventors: Ashwani Kaushal, Duncan MacIntyre
  • Patent number: 7343185
    Abstract: The present invention provides a method for identifying a concentration of a compound within a part of a subject. The method involves measuring the amount of electromagnetic radiation reflected by, or transmitted through the part with a detector, and using a quantitative mathematical analysis to determine the concentration of the compound in one, or more than one compartment, including a blood, interstitial, cellular, lymph, or bone compartment, of the part. A corrected concentration of the compound may be then determined within a compartment of interest, or a total concentration of the compound may be accurately determined. Preferably, the compound is glucose. From this determination, a clinical condition in a human or animal may be made by correlating the concentration of a measured compound in the compartment of a part of the human or animal to a clinical condition in need of treatment.
    Type: Grant
    Filed: June 18, 2003
    Date of Patent: March 11, 2008
    Assignee: NIR Diagnostics Inc.
    Inventors: James Samsoondar, Duncan MacIntyre
  • Patent number: 7328052
    Abstract: The present invention provides an apparatus and a method for identifying the risk of a clinical condition in a human or animal by correlating Near Infrared (NIR) absorbance spectral data with one or several parameters including a concentration of one or more substances in the skin, a concentration of one or more substances in skin plus subdermal tissue, a score derived from one or more clinical tests like a stress test on a treadmill, coronary angiography, or intravascular coronary ultrasound. The method determines the concentration of a compound in the skin of a human or animal and comprises the steps of placing a part of the skin against a receptor, directing electromagnetic radiation (EMR) from the near-infrared spectrum onto the skin, measuring a quantity of EMR reflected by, or transmitted through, the skin with a detector; and performing a quantitative mathematical analysis of the quantity of EMR to determine the concentration of the compound, for example free and esterfied cholesterol.
    Type: Grant
    Filed: September 17, 2004
    Date of Patent: February 5, 2008
    Assignee: NIR Diagnostics Inc.
    Inventors: James Samsoondar, Duncan MacIntyre, Ashwani Kaushal
  • Patent number: 7198955
    Abstract: A method is disclosed whereby the concentration of a blood substitute, such as cross-linked hemoglobin, in a serum or plasma specimen is rapidly and accurately identified and quantified. The method further takes the measured concentration of the blood substitute and uses it to correct for its effect, if any, on a measured analyte concentration, e.g., serum/plasma total protein. Further, the method allows for the determination of the concentration of true hemoglobin in the presence of blood substitutes. The method is carried out in respect of samples contained in a primary or secondary labelled tube, or a pipette tip used to dispense serum or plasma in a blood analyzer.
    Type: Grant
    Filed: October 16, 1997
    Date of Patent: April 3, 2007
    Assignee: NIR Diagnostics Inc.
    Inventors: James Samsoondar, Duncan MacIntyre
  • Patent number: 6995835
    Abstract: The present invention provides a method for determining a concentration of at least one analyte in a sample contained in a blood bag or in tubing in fluid communication with said blood bag, using an instrument comprising at least one calibration algorithm for the at least one analyte. The method comprises irradiating a sample in the tubing or the blood bag, using a near infrared and adjacent visible radiation source. Then measuring absorbance from the sample for the at least one analyte, and calculating a concentration of the at least one analyte using the absorbance and the at least one calibration algorithm.
    Type: Grant
    Filed: January 28, 2002
    Date of Patent: February 7, 2006
    Assignee: NIR Diagnostics Inc.
    Inventors: James Samsoondar, Duncan MacIntyre
  • Patent number: 6975891
    Abstract: The present invention provides an apparatus for measurement of Raman scattered radiation comprising. The apparatus comprises at least one source of electromagnetic radiation for producing an electromagnetic radiation beam characterized by a narrow spectral width, an integrating cavity having an interior and an exterior, wherein a sample is placed in said interior. The integrating cavity further having at least one port for insertion of the sample in the interior and for transmission of the electromagnetic radiation into and out from the interior, the at least one port extending from the exterior to said interior of said integrating cavity. The integrating cavity also comprises a first optical element for transmitting the electromagnetic radiation into the interior of the integrating cavity through the at least one port, and a second optical element for collecting Raman scattered electromagnetic radiation from the sample through the at least one port.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: December 13, 2005
    Assignee: NIR Diagnostics Inc.
    Inventor: Romuald Pawluczyk
  • Patent number: 6928311
    Abstract: A compact device (20) for non-invasively monitoring concentration levels of blood constituents, including glucose, cholesterol, alcohol, blood gases and various ions. The device includes a finger receptor (140) having a channel for receiving a finger of a user. The channel has a light entrance and a light exit so that light can be passed from a light source (91) through a finger located in the channel in a direction generally normal to the finger. Certain heat generating components, including a stable power supply for the device, are external to the device housing so as to reduce heat generation and thereby increase stability of the device. The device includes a communications interface for interacting with a computer. The device can be used for clinical use or for home use and the memory of the computer can be used to assist with record keeping and with dosage calculations.
    Type: Grant
    Filed: August 31, 2000
    Date of Patent: August 9, 2005
    Assignee: NIR Diagnostics Inc.
    Inventors: Romauld Pawluczyk, Duncan Macintyre, Bronislaw Bednarz
  • Patent number: 6919566
    Abstract: The present invention provides a method of calibrating a spectroscopic device for providing a non-invasive measurement of an analyte level in a sample. The method comprises the steps of: (a) providing a plurality of calibration algorithms; (b) taking a set of non-invasive measurements on said sample with said spectroscopic device; (c) calculating a predicted set of analyte levels for each of the calibration algorithms in response to the set of non-invasive measurements, each of the predicted sets of analyte levels being characterized by a variability range, a slope, an R2 (a square of the correlation between said set of non-invasive measurements and said predicted set of analyte levels), and a standard error of prediction; and (d) selecting an appropriate calibration algorithm by using a suitability score based on the variability range, the slope, the R2 an the standard error of prediction for each of the predicted sets of analyte levels.
    Type: Grant
    Filed: August 31, 2000
    Date of Patent: July 19, 2005
    Assignee: NIR Diagnostics Inc.
    Inventor: Theodore E. Cadell
  • Patent number: 6917422
    Abstract: The present invention provides a photometric reference member comprising PTFE and glass. The member exhibits an absorbance change of less than 0.0001 absorbance units per degree C. over a range of temperatures, preferably from about 20° C. to about 40° C., and over wavelengths from about 600 nm to about 1650 nm, preferably about 600 nm to about 1050 nm. The invention also pertains to methods of using the photometric reference member to correct for temperature variations or drift in absorbance measurements.
    Type: Grant
    Filed: January 22, 2003
    Date of Patent: July 12, 2005
    Assignee: NIR Diagnostics Inc.
    Inventors: James Samsoondar, Ashwani Kaushal
  • Patent number: 6912049
    Abstract: The present invention provides a thermally stable reference member comprising, at least one radiation attenuating element and at least one radiation scattering element. The radiation attenuating element comprising at least one aperture for transmission of radiation therethrough. The attenuating and scattering elements placed in series so that radiation transmitted through the reference member passes through each of the attenuating and scattering elements. The attenuating and scattering elements of the reference member may further comprise a thermally stable mount to hold the elements in a selected position relative to each other, and in relation to an instrument, or the elements may be bonded together.
    Type: Grant
    Filed: December 18, 2002
    Date of Patent: June 28, 2005
    Assignee: NIR Diagnostics, Inc.
    Inventors: Romuald Pawluczyk, Theodore Cadell, Bronislaw Bednarz, Ashwani Kaushal
  • Patent number: D533095
    Type: Grant
    Filed: February 15, 2005
    Date of Patent: December 5, 2006
    Assignee: NIR Diagnostics Inc.
    Inventors: Ashwani Kaushal, Duncan MacIntyre
  • Patent number: D534445
    Type: Grant
    Filed: March 4, 2005
    Date of Patent: January 2, 2007
    Assignee: NIR Diagnostics Inc.
    Inventors: Ashwani Kaushal, Duncan MacIntyre
  • Patent number: D560529
    Type: Grant
    Filed: February 7, 2007
    Date of Patent: January 29, 2008
    Assignee: NIR Diagnostics Inc.
    Inventors: Ashwani Kaushal, Duncan MacIntyre
  • Patent number: D564378
    Type: Grant
    Filed: January 3, 2007
    Date of Patent: March 18, 2008
    Assignee: NIR Diagnostics Inc.
    Inventors: Ashwani Kaushal, Duncan MacIntyre
  • Patent number: D564379
    Type: Grant
    Filed: January 19, 2007
    Date of Patent: March 18, 2008
    Assignee: NIR Diagnostics Inc.
    Inventors: Ashwani Kaushal, Duncan MacIntyre
  • Patent number: D564924
    Type: Grant
    Filed: January 5, 2007
    Date of Patent: March 25, 2008
    Assignee: NIR Diagnostics Inc.
    Inventors: Ashwani Kaushal, Duncan MacIntyre